December 20, 2021 | |
Company name | Nihon Chouzai Co., Ltd. |
Company | Yosuke Mitsuhara, President and CEO |
representative | |
Securities code | 3341; Tokyo Stock Exchange 1st |
Section | |
Contacts | Masahiro Tojo, General Manager of |
Corporate Planning Department | |
(Phone: +81-3-6810-0800) |
Notification regarding the creation of a Basic Sustainability Policy, the establishment of a
Sustainability Committee, and the identification of material issues
Nihon Chouzai Co., Ltd. (hereinafter "the Company") announces that it passed a resolution at its Board of Directors' meeting held on December 20, 2021 to create a Basic Sustainability Policy and establish a Sustainability Committee, as part of efforts to achieve a sustainable society and enhance corporate value. At a meeting of the Sustainability Committee held on the same day, the following "material issues" (key issues) were identified.
1. Goals
As societal issues and environmental issues become increasingly serious, the Nihon Chouzai Group views sustainability as an important management theme, and has created a Basic Sustainability Policy and established a Sustainability Committee chaired by the President and CEO to further strengthen and effectively execute sustainability activities. The company has also identified material issues to be given priority in the context of these activities.
2. Basic Sustainability Policy
We in the Nihon Chouzai Group are aware that sustainability is a key element of management strategies for enhancing corporate value over the medium to long term. Based on dialogues and collaborations with a wide range of stakeholders, we are building fair and highly transparent management platforms that respect human rights and take environmental protection into account. Through our business activities, we will work to solve social issues in the medical and healthcare fields and pursue social sustainability.
3. Establishment of the Sustainability Committee
(1) Roles of the Committee
This Committee, positioned directly under the jurisdiction of the Board of Directors, will supervise and evaluate the progress of activities targeting specified material issues, incorporate the results into business strategies, and deliberate on compliance with international guidelines and participation in initiatives, while
reporting to the Board of Directors as deemed appropriate.
(2) Composition of Committee Members
The sustainability committee shall be chaired by the President and CEO, and comprises committee members selected by Nihon Chouzai's Board of Directors.
4. Material issues identified
Nihon Chouzai identified 21 material issues requiring contributions to a sustainable society. Based on these material issues, which are separated into six main groups, we will promote activities from the perspectives of both contributing through business activities and strengthening the management foundations.
Key issue group | No. | Material issues | |
Increase the effectiveness of drug treatments for patients | |||
1 | by strengthening pharmacy functions (accommodate advanced | ||
healthcare and regional healthcare) | |||
Expand the functions of pharmacies to support the health of the | |||
2 | community (e.g., illness prevention and pre-symptomatic | ||
illness) | |||
3 | Contribute to social | security by ensuring appropriate use of | |
Healthcare quality and | pharmaceuticals at pharmacies | ||
accessibility | Ensure the continuous operation of pharmacies as a regional | ||
4 | healthcare/welfare infrastructure, and respond effectively to | ||
disasters, pandemics, and other crises | |||
5 | Ensure the medical safety at pharmacies | ||
6 | Leverage DX to promote online healthcare and create new | ||
business | |||
7 | Publish surveys and research that contribute | ||
to the development of healthcare | |||
Quality and stable supply of | 8 | Undertake R&D and manufacturing of safe, | |
high quality pharmaceuticals | |||
pharmaceuticals | |||
9 | Ensure a stable supply of pharmaceuticals | ||
10 | Provide "human" support in providing high-quality healthcare | ||
Resolving human issues | services | ||
at healthcare institutions | |||
11 | Support occupational health and general health, | ||
including mental health, by introducing industrial physicians | |||
Contributing to | 12 | Reduce waste materials and increase the efficiency of resource | |
a carbon-neutral, | usage, especially at pharmacies and plants | ||
2 |
circular economy | 13 | Reduce CO2 emissions by increasing energy usage efficiency |
and promoting the use of renewable energy | ||
14 | Build environment-friendly and society-friendly supply chains | |
with outstanding transparency | ||
Secure manpower that supports the company's growth, | ||
15 | and put in place HR systems that promote the growth of | |
Fostering and utilizing | employees | |
16 | Promote diversity, respect for human rights, | |
diverse manpower | ||
and the participation of women in the workplace | ||
17 | Establish a workplace environment that enhances employee | |
health and motivation | ||
18 | Support the healthcare and welfare fields (e.g., persons with | |
intractable diseases or disabilities) | ||
Strengthening governance to | 19 | Continuously strengthen corporate governance, and disclose |
information with a high level of transparency | ||
fulfill social responsibilities | ||
20 | Continuously strengthen compliance, and prevent corruption | |
21 | Create opportunities by appropriately evaluating and | |
responding to risks | ||
For further details on material issues, please refer to Nihon Chouzai's sustainability website (https://www.nicho.co.jp/en/sustainability/about/).
3
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
NIHON CHOUZAI Co. Ltd. published this content on 20 December 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 20 December 2021 08:19:15 UTC.